These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 23662044)
1. Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic carcinoma cells. Dai ZJ; Gao J; Kang HF; Ma YG; Ma XB; Lu WF; Lin S; Ma HB; Wang XJ; Wu WY Drug Des Devel Ther; 2013; 7():149-59. PubMed ID: 23662044 [TBL] [Abstract][Full Text] [Related]
2. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status. Nagata Y; Takahashi A; Ohnishi K; Ota I; Ohnishi T; Tojo T; Taniguchi S Int J Oncol; 2010 Oct; 37(4):1001-10. PubMed ID: 20811722 [TBL] [Abstract][Full Text] [Related]
3. The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cells. Hayman TJ; Wahba A; Rath BH; Bae H; Kramp T; Shankavaram UT; Camphausen K; Tofilon PJ Clin Cancer Res; 2014 Jan; 20(1):110-9. PubMed ID: 24198241 [TBL] [Abstract][Full Text] [Related]
4. A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway. Li B; Yang J; Lu Z; Liu B; Liu F J BUON; 2019; 24(2):739-745. PubMed ID: 31128031 [TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of rapamycin in pancreatic cancer cells by inducing apoptosis and autophagy. Dai ZJ; Gao J; Ma XB; Kang HF; Wang BF; Lu WF; Lin S; Wang XJ; Wu WY Int J Mol Sci; 2012 Dec; 14(1):273-85. PubMed ID: 23344033 [TBL] [Abstract][Full Text] [Related]
6. NVP-BEZ235, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, prominently enhances radiosensitivity of prostate cancer cell line PC-3. Zhu W; Fu W; Hu L Cancer Biother Radiopharm; 2013 Nov; 28(9):665-73. PubMed ID: 23768063 [TBL] [Abstract][Full Text] [Related]
7. RAD001 enhances the radiosensitivity of SCC4 oral cancer cells by inducing cell cycle arrest at the G2/M checkpoint. Yu CC; Hung SK; Liao HF; Lee CC; Lin HY; Lai HC; Li SC; Ho HC; Huang HB; Su YC Anticancer Res; 2014 Jun; 34(6):2927-35. PubMed ID: 24922656 [TBL] [Abstract][Full Text] [Related]
8. Rapamycin-induced autophagy plays a pro-survival role by enhancing up-regulation of intracellular ferritin expression in acute lymphoblastic leukemia. Gong Y; Wu J; Yang R; Zhang L; Ma Z Exp Oncol; 2020 Mar; 42(1):11-15. PubMed ID: 32231197 [TBL] [Abstract][Full Text] [Related]
9. The effects of SAHA on radiosensitivity in pancreatic cancer cells by inducing apoptosis and targeting RAD51. Wu Z; Jing S; Li Y; Gao Y; Yu S; Li Z; Zhao Y; Piao J; Ma S; Chen X Biomed Pharmacother; 2017 May; 89():705-710. PubMed ID: 28267674 [TBL] [Abstract][Full Text] [Related]
10. [Inhibition of cell growth by rapamycin through targeting mammalian target of rapamycin signaling pathway in nasopharyngeal carcinoma]. Li YL; Zhang X; Liu Y; Li SS; Xie L; Zhang N; Liu XB; Tian YQ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 45(9):765-8. PubMed ID: 21092676 [TBL] [Abstract][Full Text] [Related]
11. Arenobufagin Inhibits the Phosphatidylinositol 3-kinase/Protein Kinase B/Mammalian Target of Rapamycin Pathway and Induces Apoptosis and Autophagy in Pancreatic Cancer Cells. Wei X; Yang J; Mao Y; Zhao H; Si N; Wang H; Bian B Pancreas; 2020 Feb; 49(2):261-272. PubMed ID: 32011523 [TBL] [Abstract][Full Text] [Related]
12. [Synergistic effect of rapamycin (RPM) and PD98059 on cell cycle and mTOR signal transduction in human colorectal cancer cells]. Zhang YJ; Fang JY; Sun DF; Zhao SL; Shen GF; Zheng Q; Zhu HY Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):889-93. PubMed ID: 18478925 [TBL] [Abstract][Full Text] [Related]
13. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity. Bi YL; Min M; Shen W; Liu Y Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287 [TBL] [Abstract][Full Text] [Related]
14. The effect of ibrutinib on radiosensitivity in pancreatic cancer cells by targeting EGFR/AKT/mTOR signaling pathway. Tan B; Huang Y; Zhang B; Lin N Biomed Pharmacother; 2020 Aug; 128():110133. PubMed ID: 32447207 [TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum stress sensitizes human esophageal cancer cell to radiation. Pang XL; He G; Liu YB; Wang Y; Zhang B World J Gastroenterol; 2013 Mar; 19(11):1736-48. PubMed ID: 23555162 [TBL] [Abstract][Full Text] [Related]
16. The Combination of Trametinib, a MEK Inhibitor, and Temsirolimus, an mTOR Inhibitor, Radiosensitizes Lung Cancer Cells. Kim SY; Jeong EH; Lee TG; Kim HR; Kim CH Anticancer Res; 2021 Jun; 41(6):2885-2894. PubMed ID: 34083279 [TBL] [Abstract][Full Text] [Related]
17. Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model. Kim KW; Moretti L; Mitchell LR; Jung DK; Lu B Clin Cancer Res; 2009 Oct; 15(19):6096-105. PubMed ID: 19773376 [TBL] [Abstract][Full Text] [Related]
18. The mTOR inhibitor RAD001 sensitizes tumor cells to the cytotoxic effect of carboplatin in breast cancer in vitro. Liu H; Zang C; Schefe JH; Schwarzlose-Schwarck S; Regierer AC; Elstner E; Schulz CO; Scholz C; Possinger K; Eucker J Anticancer Res; 2011 Sep; 31(9):2713-22. PubMed ID: 21868512 [TBL] [Abstract][Full Text] [Related]
19. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401 [TBL] [Abstract][Full Text] [Related]
20. Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor. Zou CY; Smith KD; Zhu QS; Liu J; McCutcheon IE; Slopis JM; Meric-Bernstam F; Peng Z; Bornmann WG; Mills GB; Lazar AJ; Pollock RE; Lev D Mol Cancer Ther; 2009 May; 8(5):1157-68. PubMed ID: 19417153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]